Plasminogen activator inhibitor-1 (PAI-1), as a key regulator of fibrinolysis, has recently been implicated in structural airway changes and persistent inflammation in patients with COPD. The gene discussed is SERPINE1; the disease is chronic obstructive pulmonary disease.